clinicalID: v-procedure-specificity
Procedure Specificity Validation
This validation scans consent forms to verify that specific medical procedures or clinical investigations are explicitly named. It prevents the use of vague, general phrasing like general care or standard study protocol. The auditor requires precise clinical terminology so that participants understand the exact intervention they are authorizing.
Specific procedure disclosure is required under FDA 21 CFR Part 11 and HHS Common Rule guidelines. Informing participants of the exact clinical steps validates their consent and reduces institutional liability.
clinicalID: v-risk-benefit-balance
Risk-Benefit Balance Audit
This rule analyzes the description of potential benefits and verifies that a corresponding risks and complications section is present. It flags forms that present one-sided marketing language, ensuring that the visual weight and detailing of risks balances any stated advantages.
Maintaining a balanced presentation of risks and benefits satisfies clinical ethics standards under the Declaration of Helsinki. It guarantees that the participant receives an objective assessment of the study outcomes.
clinicalID: v-revocation-clause
Revocation Right Verification
This check scans the consent text for explicit language confirming that the participant has the right to withdraw from the research study or medical treatment at any time. The clause must state that withdrawal involves no penalty and does not forfeit access to alternate standard clinical care.
Withdrawal rights are mandated by FDA 21 CFR 50.25 and 45 CFR 46.116. Verifying this clause ensures that participant participation remains entirely voluntary throughout the trial lifecycle.
clinicalID: v-explanation-affirmation
Explanation and Dialogue Affirmation
This validator verifies the inclusion of a practitioner statement affirming that a meaningful, two-way dialogue has occurred. This check ensures the physician has explained the clinical procedure, outlined alternatives, and answered all questions prior to signing.
Under CMS Conditions of Participation, informed consent is defined as a communicative process, not merely a signature. Documenting this dialogue protects both patient autonomy and provider liability.
clinicalID: v-capacity-assessment
Task-Specific Capacity Verification
This rule ensures that the consent process documents a task-specific capacity assessment. It checks for declarations indicating that the patient has the cognitive capacity to understand the specific clinical decisions at the time of signing.
Task-specific capacity assessments align with TJC guidelines. Institutional records must verify capacity for complex medical decisions before procedures can legally go forward.
clinicalID: v-psych-authorization
Psychiatric Consent Depth Audit
This validation applies to mental health consent documents, verifying the presence of core clinical disclosures. It checks for statements on the nature of the illness, the proposed treatment plan, associated side effects, the prognosis with treatment, the prognosis without treatment, and the right to refuse.
Satisfying psychiatric consent requirements aligns with State Mental Health Acts. It ensures that vulnerable psychiatric patients receive comprehensive disclosures before undergoing high-risk treatments.
clinicalID: v-minor-permission
Parental Permission Enforcer
This check detects if the participant profile indicates a minor age. It blocks forms that use passive opt-out consent mechanisms, enforcing active, written parental or legal guardian permission blocks by default.
Research involving children requires active parent or guardian permission under HHS 45 CFR 46 Subpart D. Enforcing active consent blocks prevents regulatory violations in pediatric research.
clinicalID: v-reproductive-rights
Reproductive Examination Disclosure
This check scans surgical consent documents for procedures under general anesthesia to ensure explicit, separate written authorization is obtained for sensitive reproductive, pelvic, or rectal physical examinations.
Under HHS directives on consent for sensitive examinations, general surgical consent forms do not cover sensitive exams. Providing standalone reproductive exam opt-ins prevents severe legal liabilities.
clinicalID: v-genetic-privacy
Genetic Privacy Disclosure (GINA)
This rule verifies the inclusion of a genetic privacy statement in studies that involve DNA collection, biospecimen storage, or hereditary tracking. The form must state that genetic details cannot be used to affect health insurance or employment.
Genetic data requires explicit privacy protections under the Genetic Information Nondiscrimination Act and GDPR Article 9. This check ensures that participants are informed of their statutory protections.
clinicalID: v-general-scope-delineation
General Consent Scope Delineation
This validator verifies that general admission or general treatment forms explicitly state that authorization is limited to routine clinical care. It must exclude invasive surgical procedures, anesthesia, or experimental research.
Under CMS Conditions of Participation, general consents cannot be used to authorize high-risk procedures. This check prevents clinical staff from using general forms for specialized interventions.
clinicalID: v-sud-disclosure
Substance Use Disorder Disclosure
This check audits records involving Substance Use Disorder data sharing. It verifies that authorizations include explicit redisclosure warnings, name the specific recipients, and are not bundled with general legal or counseling notes.
Substance Use Disorder records require standalone, unbundled authorizations under federal 42 CFR Part 2 rules. Ensuring proper redisclosure warnings avoids severe regulatory penalties.
clinicalID: v-identity-disclosure
Healthcare Identity Verification
This validator scans the administrative header block to ensure that both the hosting healthcare facility and the primary attending clinician or principal investigator are explicitly named, preventing the use of anonymous placeholders.
Attending practitioner identification is required under CMS Hospital Conditions of Participation. Identifying the performing clinician is necessary to establish valid informed consent.
clinicalID: v-contact-transparency
Contact Transparency Audit
This check ensures the consent document lists a specific point of contact, telephone number, and email address for questions about research rights and for reporting study-related injuries. This contact info must be distinct from emergency services.
Providing direct contact details for questions and injuries is required under FDA 21 CFR 50.25. This ensures participants have an operational path to report adverse events.
clinicalID: v-copy-disclosure
Consent Copy Provision Assurance
This check verifies the presence of a statement informing the participant that a copy of the completed, signed consent document will be provided to them automatically via secure email or a secure download link.
Under ICH GCP E6 guidelines, participants must receive a copy of the signed document. This check guarantees that organizations establish transparent document delivery workflows.
clinicalID: v-confidentiality-disclosure
Confidentiality Scope Assurance
This validator verifies that every clinical and research form contains a statement describing how the confidentiality of participant records will be maintained, listing specific entities that may inspect the data.
Informing participants of confidentiality scopes is required by FDA 21 CFR 50.25 and the HIPAA Privacy Rule. Listing authorized regulatory inspectors helps set compliant data sharing expectations.
regulatoryID: v-no-exculpatory
No-Exculpatory Language Scan
This check scans the entire text for words or sentences that waive or appear to waive the participant's legal rights. It flags phrases that release the investigator, sponsor, or clinical facility from liability for negligence, which would void the consent.
Exculpatory language is strictly prohibited in informed consent under FDA 21 CFR 50.20 and HHS 45 CFR 46.116. Removing liability release sentences is essential to prevent immediate IRB rejection.
regulatoryID: v-no-conditioning
No-Conditioning Authorization Audit
This check ensures that general healthcare treatment is not conditioned on the participant signing optional research authorizations. It verifies that optional data sharing is separated from clinical treatment authorizations.
Conditioning standard healthcare services on optional research sign-offs is illegal under the HIPAA Privacy Rule. Keeping treatment consent unconditioned protects participant choices.
regulatoryID: v-interpreter-integrity
Interpreter Integrity Check
This validator scans linguistic and metadata fields to verify that a qualified interpreter is designated if the participant requires translation. The rule blocks any attempts to list minor family members as translators or interpreters.
Using minor children as translators is illegal in healthcare under Section 1557 of the Affordable Care Act. This check ensures that communication remains accurate and legally compliant.
regulatoryID: v-assent-witness
Assent Witness Independence
This check ensures that the parent or legal guardian who signed parental permission is not listed as the impartial witness for the child's assent signature, protecting the independence of the assent verification.
Under HHS 45 CFR 46, independent verification is required for vulnerable populations participating in clinical trials. Restricting parent-witness overlap ensures an objective signature process.
regulatoryID: v-signature-integrity
Signature Block Structural Audit
This check verifies the integrity of the signature blocks, ensuring that required fields such as date, time, and role designation are present and cannot be bypassed or modified by the signer.
Electronic signatures must display the printed name, date, time, and meaning of the signature under FDA 21 CFR Part 11. Complete structural metadata is necessary to ensure document validity.
regulatoryID: v-signature-role-limit
Signature Role Limit Validation
This rule ensures that a single user profile cannot execute multiple distinct signature roles on the same document, such as acting as both the primary clinician and the impartial witness.
Enforcing separation of duties prevents fraudulent signatures under FDA Part 11 and ICH GCP guidelines. Restricting role overlap preserves the integrity of the signing ceremony.
linguisticID: v-reading-level
Flesch-Kincaid Readability Auditor
This check runs readability calculations across all narrative blocks to check comprehension accessibility. It warns the user if the text complexity exceeds the targeted grade level, ensuring the form remains readable for the general public.
Consent materials must be written in language that is understandable to the subject under the HHS Common Rule. Evaluating reading difficulty prevents cognitive overload during the review process.
linguisticID: v-medical-jargon-check
Medical Jargon and Terminology Scan
This validator scans disclosures for complex clinical terms. It flags these terms and recommends replacing them with plain-language terms or embedding interactive definition tooltips directly in the digital layout.
Avoiding technical jargon that limits participant understanding aligns with FDA Guidance on Informed Consent. Simplifying terminology ensures that consent is truly informed.
linguisticID: v-placeholder-integrity
Placeholder and Tag Integrity Audit
This rule scans the template text for orphaned bracketed fields that lack data mapping in the active registry, preventing incomplete forms from being presented to patients.
Documents must be complete and free of unresolved fields to be legally binding under UETA and the ESIGN Act. Resolving placeholders prevents critical document omissions.
identityID: v-relation-authority
Guardian Relationship Authority Validation
This check verifies that when a Legally Authorized Representative or parent signs on behalf of a participant, a relationship selection dropdown field is included to specify their legal authority.
Documenting the legal authority of the representative is required under State Probate Codes and clinical trial guidelines. This check ensures the authorization chain is complete.
identityID: v-signatory-match
Signatory Signature Block Match
This validator verifies that every signatory role described in the introduction or participant profile has a corresponding, active signature pad block configured in the layout, preventing missing signatures.
All designated signatories must execute their signatures to validate the record under FDA 21 CFR Part 11. Matching signatory roles to layout blocks ensures complete execution.
identityID: v-legal-guardian-trigger
Legal Guardian Requirement Trigger
This check analyzes participant age metadata. If the participant age is under the legal threshold for consent or exceeds 89 years, this trigger requires the insertion of parental or Legally Authorized Representative fields.
Satisfying State Age of Majority Statutes and HIPAA Safe Harbor guidelines requires structured LAR inputs. This trigger automates representative assignment for vulnerable signers.
linguisticID: v-teach-back-suggest
Teach-Back Quiz Suggestion Engine
This validator analyzes the clinical complexity score of the procedure. If the risk level exceeds baseline parameters, this check recommends embedding a teach-back quiz to verify participant understanding.
Under TJC Patient Education Guidelines, high-risk procedures require verification of patient understanding. Suggesting teach-back quizzes helps clinics meet comprehension standards.
safe-harborID: v-leak-detection
Plaintext Identity Leak Detection
This rule scans all narrative sections for exposed personal identifiers, such as social security numbers, phone numbers, email addresses, or payment card numbers, before the document is published.
Sensitive personal data must be protected and restricted under the HIPAA Security Rule and GDPR. Blocking plaintext identity leaks prevents accidental data exposure.
safe-harborID: v-age-89-redaction
Safe Harbor Age Redaction
This check analyzes date-of-birth fields and age calculations. If a participant's age is over 89, the rule redacts specific age numbers and replaces them with an age over 89 placeholder to maintain de-identification.
Specific ages over 89 must be redacted to protect identity under the HIPAA Safe Harbor Standard. This check automates de-identification for elderly participants.
safe-harborID: v-geo-granularity
Geographic Granularity Masking
This validator scans location and address inputs to verify that street-level indicators are not stored in plaintext. It enforces county or state-level masking for de-identified forms to comply with HIPAA.
Under the HIPAA Safe Harbor Standard, geographic details smaller than a state or three-digit ZIP code must be redacted. Truncating addresses keeps data safe during reviews.
regionalID: v-reg-california-ccpa
California CCPA Disclosures
This rule checks if California is selected as the participant location. If so, it verifies that the privacy disclosures include CCPA notices, detailing consumer rights and data opt-out links.
California residents must receive CCPA rights notices under the California Consumer Privacy Act. This check automates regional privacy compliance for California signers.
regionalID: v-reg-eu-gdpr-dpo
EU GDPR Data Protection Officer Disclosure
This validator verifies the presence of the Data Protection Officer contact details in the privacy disclosures if the form involves participants residing within the European Union.
Organizations processing sensitive health data at scale must publish DPO contact details under GDPR Article 37. This check guarantees that European trials meet disclosure standards.
regionalID: v-reg-india-dpdp
India DPDP Notice Compliance
This check ensures that DPDP Act notices accompany the consent request if the participant is located in India. The notice must specify the categories of personal data collected and the purpose of processing.
Processing personal data in India requires explicit purpose-limited notices under the Digital Personal Data Protection Act. This check ensures compliance for Indian research sites.